Work

Correction: Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

Year: 2020

Type: erratum

Abstract: Alvarez de Cienfuegos A, Cheung LH, Mohamedali KA, et al . Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B. J Immunother Cancer 2020;8:e001138. doi: 10.1136/jitc-2020-001138. This article has been corrected since it

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1136/jitc-2020-001138corr1

Authors: Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin

Institutions: The University of Texas MD Anderson Cancer Center, Shandong Tumor Hospital, Shandong First Medical University, Allegheny General Hospital

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490

OpenAlex ID: W4233214970

Cites:

Cited by:

Related to: 10